tiprankstipranks
Cardiol Therapeutics (TSE:CRDL)
TSX:CRDL
Canadian Market

Cardiol Therapeutics (CRDL) Cash flow

Compare
155 Followers

Cardiol Therapeutics Cash Flow

TSE:CRDL's free cash flow for Q3 2024 was C$-7.78M. For the 2024 fiscal year, TSE:CRDL's free cash flow was decreased by C$27.30M and operating cash flow was C$-7.77M. See a summary of the company’s cash flow.
Cash Flow
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
-C$ -27.22MC$ -23.55MC$ -9.19MC$ -11.38M
Investing Cash Flow
C$ -64.31KC$ -74.71KC$ -12.92KC$ -40.60KC$ -424.31K
Financing Cash Flow
-C$ -53.93KC$ 93.44MC$ 16.30MC$ 2.03M
End Cash Position
C$ 34.93KC$ 59.47MC$ 83.90MC$ 14.03MC$ 6.96M
Free Cash Flow
-C$ -27.30MC$ -23.56MC$ -9.23MC$ -11.80M
Currency in CAD

Cardiol Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis